单位：[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China内科学系血液内科华中科技大学同济医学院附属同济医院[2]Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China
This work was supported by the National Natural Science Foundation of China
(No. 81770211 and No. 82270203 to M.X.).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|4 区医学
小类|4 区血液学
最新[2025]版：
大类|4 区医学
小类|4 区血液学
第一作者：
第一作者单位：[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China[2]Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China[2]Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei 430030, China[*1]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China
推荐引用方式(GB/T 7714)：
Deng Xinyue,Ge Tong,Shen Kefeng,et al.Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs)[J].Blood Science (Baltimore, Md.).2024,6(1):e00180.doi:10.1097/BS9.0000000000000180.
APA：
Deng Xinyue,Ge Tong,Shen Kefeng,Wang Jiachen,Mu Wei...&Xiao Min.(2024).Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs).Blood Science (Baltimore, Md.),6,(1)
MLA：
Deng Xinyue,et al."Novel heterozygous mutations of TNFRSF13B in EBV-associated T/NK lymphoproliferative diseases (EBV-T/NK-LPDs)".Blood Science (Baltimore, Md.) 6..1(2024):e00180
